BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25472586)

  • 1. Clinical implication of CD166 expression in salivary gland tumor.
    Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
    Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
    Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
    Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of the expression of human chorionic gonadotropin-β in salivary gland tumors.
    Meda S; Reginald BA; Reddy BS
    J Cancer Res Ther; 2018; 14(5):952-956. PubMed ID: 30197330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
    Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
    Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.
    Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y
    Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of DNA content in salivary gland tumors].
    Yáñez M; Roa I; Villaseca M; Fuentealba P
    Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
    Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
    Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ras-P21 in salivary gland tumors.
    Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
    Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
    Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
    Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors.
    Al-Rawi NH; Omer H; Al Kawas S
    J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
    Toper MH; Sarioglu S
    Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation.
    Jaafari-Ashkavandi Z; Ashraf MJ; Abbaspoorfard AA
    Braz J Otorhinolaryngol; 2019; 85(2):144-149. PubMed ID: 29339028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
    Queimado L; Lopes CS; Reis AM
    Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
    Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
    Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
    Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
    Darling MR; Hashem NN; Zhang I; Mohamed AB; Fung K; Kwan K; Mara TW; Daley TD; Diamandis EP
    Int J Biol Markers; 2012 Dec; 27(4):e381-8. PubMed ID: 23250777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
    von Holstein SL
    Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
    Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
    Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49.
    Epivatianos A; Poulopoulos A; Kayavis I; Papanayotou P
    Oral Dis; 2000 Mar; 6(2):112-7. PubMed ID: 10702789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.